Caricamento...
Anti-programmed cell death protein-1/ligand-1 therapy in different cancers
Immunologic checkpoint blockade with antibodies against the programmed cell death protein-1 (PD-1) or its ligand (PD-L1) is an effective method for reversing cancer immunosuppression and thereby promoting immune responses against several cancer types. Anti-PD-1 and anti-PD-L1 antibodies have resulte...
Salvato in:
| Pubblicato in: | Br J Cancer |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Publishing Group
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4453674/ https://ncbi.nlm.nih.gov/pubmed/25856776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.124 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|